Andrx, Schering Settle Claritin-D Patent Dispute
Andrx Corp. settled a patent dispute with Schering-Plough Corp. over Andrx's generic version of the Claritin-D 24-hour allergy medicine, the companies said Friday....To view the full article, register now.
Already a subscriber? Click here to view full article